# Selective Pelvic Lymphadenectomy for IB-IIA Cervical Cancer

> **NCT03295526** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 200 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **PROCEDURE:** Lymph nodes debulking surgery.

## Key facts

- **NCT ID:** NCT03295526
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03295526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03295526, "Selective Pelvic Lymphadenectomy for IB-IIA Cervical Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03295526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*